Healthcare and Pharmaceutical Amyotrophic Lateral Sclerosis Treatment Market

Amyotrophic Lateral Sclerosis (ALS) Treatment Market
- Size, Share, Emerging Trends, Outlook, and
Opportunity Analysis, 2018 – 2026
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market, By Drug Type
(Riluzole and Edaravone (Radicava)), By Distribution Channel (Hospital
Pharmacies, and Retail & Online Pharmacies), and by Geography
Global Amyotrophic Lateral Sclerosis (ALS) Treatment Market
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease and motor neuron disease
(MND), is a neurodegenerative disease, affecting nerve cells in the brain and spinal cord that controls
voluntary muscles. The disease is progressive in nature, meaning it gets worse over time.
According to a study published in Centers for Disease Control and Prevention, in 2016, around
14,713 people were diagnosed with ALS in the U.S. and prevalence rate of ALS was 4.7 cases per
100,000 people in 2012. The prevalence rate increased to 5.0 cases per 100,000 people and around
15,908 people were diagnosed with ALS in 2013, according to the same study. The increasing
prevalence of ALS is in turn, expected to support growth of the amyotrophic lateral sclerosis (ALS)
treatment market in the near future.
Approval of novel innovative drugs is expected to boost growth in amyotrophic lateral
sclerosis treatment market
In May 2017, The U.S. Food and Drug Administration (FDA) approved Radicava (edaravone), an
innovative drug used in the treatment of amyotrophic lateral sclerosis (ALS). This was the first drug to
be approved after over 20 years since the last FDA-approved drug for ALS. The approval of this drug
would provide an additional option for patients suffering from this deadly disease. Increasing
incidence of ALS is expected to increase the adoption rate of this drug, in turn, boosting market
growth. The drug has already been approved in Japan and South Korea in 2015.
Download PDF Brochure of Market Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1206
Initiatives taken by some associations to increase awareness about diagnosis and treatment of ALS
among population is also expected to drive market growth during forecast period (2017-2025). For
instance in 2014, the ALS Ice Bucket Challenge, a social media–centered campaign, received